Find research datasets worth reusing

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (

ClinicalTrials.gov study NCT01721876. IPD Sharing: NO. Countries: 25. Publications: 1.

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

ClinicalTrials.gov study NCT02540954. IPD Sharing: NO. Countries: 14. Publications: 1.

COMPASS 65+ - Community-based Physical Activity Snacks for Healthy Aging in Overweight and Obese Aged Adults

ClinicalTrials.gov study NCT07289529. IPD Sharing: NO. Countries: 1. Publications: 10.

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov study NCT02247531. IPD Sharing: Not stated. Countries: 22. Publications: 7.

Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women

ClinicalTrials.gov study NCT02250534. IPD Sharing: Not stated. Countries: 1. Publications: 6.

Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years

ClinicalTrials.gov study NCT04068948. IPD Sharing: NO. Countries: 1. Publications: 11.

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

ClinicalTrials.gov study NCT01511250. IPD Sharing: Not stated. Countries: 4. Publications: 6.

Dietary Nitrate and Muscle Power With Aging

ClinicalTrials.gov study NCT03513302. IPD Sharing: NO. Countries: 1. Publications: 7.

A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation Th

ClinicalTrials.gov study NCT02412111. IPD Sharing: Not stated. Countries: 10. Publications: 1.

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov study NCT05019521. IPD Sharing: Not stated. Countries: 13. Publications: 1.

Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age

ClinicalTrials.gov study NCT02418455. IPD Sharing: Not stated. Countries: 3. Publications: 3.

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

ClinicalTrials.gov study NCT06528691. IPD Sharing: YES. Countries: 2. Publications: 0.

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

ClinicalTrials.gov study NCT01949090. IPD Sharing: Not stated. Countries: 2. Publications: 1.

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

ClinicalTrials.gov study NCT04026113. IPD Sharing: YES. Countries: 14. Publications: 1.

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cysti

ClinicalTrials.gov study NCT02137382. IPD Sharing: Not stated. Countries: 2. Publications: 1.

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

ClinicalTrials.gov study NCT00501293. IPD Sharing: NO. Countries: 1. Publications: 1.

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma

ClinicalTrials.gov study NCT02483975. IPD Sharing: YES. Countries: 2. Publications: 1.

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

ClinicalTrials.gov study NCT01718509. IPD Sharing: Not stated. Countries: 2. Publications: 5.

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

ClinicalTrials.gov study NCT00481767. IPD Sharing: YES. Countries: 2. Publications: 3.

Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years

ClinicalTrials.gov study NCT03587207. IPD Sharing: YES. Countries: 1. Publications: 1.